Research out of Europe shows that fecal transplants may be an effective treatment for people with end-stage chronic liver disease.
The transplants work by replacing “bad” bacteria in the gut microbiome with “good” bacteria from a healthy donor.
Fecal transplant pills have been approved in the United States to treat C. difficile infection.
In addition to the cirrhosis research, there are a number of other potential applications for fecal transplantation.